COVID-19: Vaccines and Therapeutics

Dec 22, 2020
The COVID-19 Vaccine Communications Toolkit was developed as a guide through the steps involved in planning, designing and executing a vaccine communications plan and campaign.
Dec 21, 2020
At a Glance House and Senate leaders late yesterday announced an agreement on a roughly $900 billion COVID-19 relief package that includes a number of provisions beneficial to hospitals and health systems. They also agreed on a roughly $1.4 trillion spending package that would fund the federal…
Dec 18, 2020
Centers for Medicare & Medicaid Services released updated guidance for states and territories on Medicaid, Children’s Health Insurance Program and Basic Health Program coverage and reimbursement for COVID-19 vaccinations.
Dec 18, 2020
The American Medical Association announced Current Procedural Terminology immunization and administration codes for reporting on medical claims the COVID-19 vaccine under development by AstraZeneca and University of Oxford.
Dec 18, 2020
The National Institutes of Health announced enrollment in phase 3 of the clinical trial of two disparate therapies. This trial is specifically looking at the safety and effectiveness of the therapeutics in people hospitalized with moderate COVID-19 symptoms.
Dec 18, 2020
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Dec. 17 recommended the approval of Moderna’s mRNA-1273 COVID-19 vaccine candidate.
Dec 18, 2020
To help advance the public’s confidence and trust in the safety of COVID-19 vaccines and their distribution, the AHA has launched a COVID-19 vaccine webpage for individuals.
Dec 17, 2020
As the nation grapples with the complicated logistics of fair and efficient vaccine distribution, this conversation with two senior officials from the National Urban League explores best practices and strategies hospitals and health systems can use to reach Black, Latinx and underserved communities…
Dec 17, 2020
AHA launched #MyWhy, a social media campaign that amplifies health care workers’ voices on the importance of getting vaccinated against COVID-19.
Dec 17, 2020
The Food and Drug Administration Center for Biologics Evaluation and Research Prevention has addressed new information that shipped vials of Pfizer’s BND162b2 mRNA COVID-19 vaccine contain extra doses, indicating that it is acceptable to use every full dose obtainable from each product vial.